Publication Name	World Journal of Critical Care Medicine
Manuscript ID	72354
Country	United States

Category	Critical Care Medicine
Manuscript Type	Retrospective Study
Article Title	Retrospective analysis of aspirin's role in the severity of COVID-19 pneumonia
Manuscript Source	Unsolicited Manuscript
All Author List	Maya Gogtay, Yuvaraj Singh, Asha Bullappa and Jeffrey Scott
Funding Agency and Grant Number
Corresponding Author	Maya Gogtay, MD, Doctor, Internal Medicine, Saint Vincent Hospital, 123 Summer street, Worcester, MA 01604, United States. drgogtay@gmail.com
Key Words	COVID-19; Aspirin; Intensive care unit progression; Antiplatelet; Hypercoagulability; Anti-inflammatory
Core Tip	Our study suggests that aspirin has no beneficial effects with regards to progression to intensive care unit (ICU) from the medical floors in COVID-19 positive patients. This study was conducted on the patients presenting during the early phase of the pandemic when there was little evidence on the most beneficial modality of treatment. Over the last 2 years we have learned about the pro-thrombotic nature of COVID-19. Since aspirin is a widely dispensed medication in our adult population, we questioned if its chronic use could have a preventive effect on ICU progression of patients admitted to the medical floors. However, our data analysis suggests that there was no such protective effect.
Citation	Gogtay M, Singh Y, Bullappa A, Scott J. Retrospective analysis of aspirin's role in the severity of COVID-19 pneumonia. World J Crit Care Med 2022; 11(2): 92-101

Received	2021-11-18 15:37
Peer-Review Started	2021-11-18 15:39
To Make the First Decision
Return for Revision	2021-12-27 02:47
Revised	2022-01-03 01:53
Second Decision	2022-01-19 03:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-01-20 05:08
Articles in Press	2022-01-20 05:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-02-25 07:33

ISSN	2220-3141(online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com